Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Pamela Spicer

Analyst

About Pamela

USA

+8 year(s) experience

As an Analyst with Trialtrove, Pamela Spicer develops and manages clinical trials content. She covers the autoimmune/inflammation, CNS, and ophthalmology therapeutic areas.

Specialties

CNS
Immunology & Inflammation

Pamela Writes For

Trialtrove: gold standard clinical trials intelligence

Skipta, Citeline

A Nautical but Nice Look at BTK inhibitors for Rheumatoid Arthritis

By Pamela Spicer 15 Jun 2019

Skipta, the leading social network of specialized online medical communities for verified healthcare professionals, recently hosted a virtual advisory board session, through its proprietary Skipta Gather technology, asking physicians what they saw as the current unmet needs in the treatment of rheumatoid arthritis (RA).

Topic Arthritis

Read blog
Trialtrove

Strategies To Maintain Top Positions In Autoimmune and Inflamation

By Pamela Spicer 22 Mar 2017

A Steady Course: Strategies to Maintain Top Positions in Autoimmune/ Inflammation

View white paper
Trialtrove

IL-6: Vying for a Sliver of the Rheumatoid Arthritis Pie

By Pamela Spicer 19 Dec 2016

TNF antagonists have played a major role in rheumatoid arthritis (RA) prescribing trends, even helping to make adalimumab (Humira) and etanercept (Enbrel) rank among the top selling products.

Topic Arthritis

Read blog
Citeline

Amyloid Targeting Treatments in Alzheimer’s Disease

By Pamela Spicer 12 Feb 2016

The underlying causes for cognitive and functional symptoms associated with Alzheimer’s disease (AD) have been explained by the amyloid hypothesis.

Topic Alzheimers

Read blog

Latest headlines from Pamela

Pink Sheet

04 Jul 2016

Better Supplement Industry Self-Regulation Slows Enforcement 'Hammer' –Indiana AG

Link
Pink Sheet

27 Jun 2016

Need For Better Research Grows With Supplements' Popularity – NCCIH

Link
Pink Sheet

21 Jun 2016

Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile

Link
Pink Sheet

20 Jun 2016

Prosecutions Send Spiked Consumer Health Product Marketers To Prison

Link
Pink Sheet

13 Jun 2016

All Economies Are Local In CRN Tool With Analysis Of Supplement Industry Impact

Link
Pink Sheet

06 Jun 2016

Investor Pressure Hits SunOpta During Listeria Contamination Response

Link
Pink Sheet

03 Jun 2016

Church & Dwight Makes A Toppik Of E-Commerce Sales Growth

Link
Pink Sheet

17 May 2016

More Than 100 Herbal Supplements On Recall Under Consent Decree

Link
Pink Sheet

11 May 2016

Online: Where Supplement Users Most Often Get Product Information – FDA Survey

Link
Pink Sheet

05 May 2016

Vitamin Shoppe Fits Product Innovation Into Ongoing Overhaul

Link
Pink Sheet

03 May 2016

Supreme Court Slays POM Wonderful's Appeal Of FTC Order

Link
Pink Sheet

29 Apr 2016

GNC Hits Revenue Wrinkles As It Irons Out Marketing, Franchise Shifts

Link
Pink Sheet

21 Apr 2016

One-Two Punch On Supplements From Former FDA Investigator, Harvard Researchers

Link
Pink Sheet

18 Apr 2016

Acne Drug Switch Study Stirs FDA Doubts About Pregnant Women's Self-Selection

Link
Pink Sheet

18 Apr 2016

Galderma's Acne Drug OTC Switch Gets Unanimous Advisory Cmte. Support

Link

Pamela Spicer

About Pamela

Analyst Articles

Articles by Pamela

A Nautical but Nice Look at BTK inhibitors for Rheumatoid Arthritis

Strategies To Maintain Top Positions In Autoimmune and Inflamation

IL-6: Vying for a Sliver of the Rheumatoid Arthritis Pie

Amyloid Targeting Treatments in Alzheimer’s Disease

Latest headlines from Pamela

Better Supplement Industry Self-Regulation Slows Enforcement 'Hammer' –Indiana AG

Need For Better Research Grows With Supplements' Popularity – NCCIH

Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile

Prosecutions Send Spiked Consumer Health Product Marketers To Prison

All Economies Are Local In CRN Tool With Analysis Of Supplement Industry Impact

Investor Pressure Hits SunOpta During Listeria Contamination Response

Church & Dwight Makes A Toppik Of E-Commerce Sales Growth

More Than 100 Herbal Supplements On Recall Under Consent Decree

Online: Where Supplement Users Most Often Get Product Information – FDA Survey

Vitamin Shoppe Fits Product Innovation Into Ongoing Overhaul

Supreme Court Slays POM Wonderful's Appeal Of FTC Order

GNC Hits Revenue Wrinkles As It Irons Out Marketing, Franchise Shifts

One-Two Punch On Supplements From Former FDA Investigator, Harvard Researchers

Acne Drug Switch Study Stirs FDA Doubts About Pregnant Women's Self-Selection

Galderma's Acne Drug OTC Switch Gets Unanimous Advisory Cmte. Support